adding immunotherapy to first-line chemotherapy for gastric cancer: data and implications
Published 3 years ago • 225 plays • Length 14:12Download video MP4
Download video MP3
Similar videos
-
5:09
adding immunotherapy to first-line chemotherapy for gastric cancer: data from attraction-4
-
9:44
adding first-line nivolumab to chemotherapy for advanced gastric, ge junction, and esophageal adenoc
-
13:32
asco: new data and implications for immunotherapy in gastric cancer
-
2:39
first line immunotherapy/chemotherapy in her2- gastric cancer in japan
-
5:51
immunotherapy in chemorefractory gastric cancer
-
2:29
overcoming resistance to immunotherapy as first-line therapy in gastric cancer
-
7:00
interpretation of data on immunotherapy use in gastric cancer
-
1:07
dr. smaglo on the future of immunotherapy in gastric cancer
-
56:48
immunotherapy for gastroesophageal cancer
-
1:04
panthera: pembrolizumab, trastuzumab, and chemotherapy in her2 advanced gastric cancer
-
3:18
immune checkpoint inhibitors and combination strategies for patients with gastric cancer
-
1:07:30
personalizing gastric cancer care with her2-targeted and other novel therapies
-
0:31
tislelizumab in first-line treatment for advanced gastric cancer #oncology #pencis #lecture #antipd1
-
22:39
gastric cancer: update on first-line therapies
-
10:54
asco gi: adding lenvatinib to pembrolizumab in patients with advanced gastric cancer
-
3:57
pembrolizumab plus 5-fu and cisplatin for first-line treatment in...
-
1:00
navigating stage 4 gastric cancer and finding hope in immunotherapy
-
30:31
gastroesophageal cancer: current positioning of immunotherapy
-
7:02
later lines of therapy in metastatic gastric cancer